Am J Physiol Cell Physiol Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Cell Physiol 286: C1170-C1176, 2004. First published January 7, 2004; doi:10.1152/ajpcell.00306.2003
0363-6143/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
286/5/C1170    most recent
00306.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Castilla, M. A.
Right arrow Articles by Caramelo, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Castilla, M. A.
Right arrow Articles by Caramelo, C.

VASCULAR BIOLOGY

Tumor-induced endothelial cell activation: role of vascular endothelial growth factor

M. Ángeles Castilla,1,2 Fernando Neria,1,2 Guadalupe Renedo,1 Daniel S. Pereira,3 Francisco R. González-Pacheco,1,2 Sonsoles Jiménez,1 Paloma Tramón,1 J. J. P. Deudero,1 M. V. Alvarez Arroyo,1,2 Susana Yagüe,1,2 and Carlos Caramelo1,2,4

1Instituto de Investigaciones Médicas, Fundación Jiménez Díaz; 4Universidad Autónoma de Madrid, and 2Instituto Reina Sofía de Investigación Nefrológica, 28040 Madrid, Spain; and 3Molecular and Cell Biology Department, Imclone Systems Incorporated, New York, New York 10014

Submitted 17 July 2003 ; accepted in final form 23 December 2003

Proangiogenic, proliferative effects of tumors have been extensively characterized in subconfluent endothelial cells (EC), but results in confluent, contact-inhibited EC are critically lacking. The present study examined the effect of tumor-conditioned medium (CM) of the malignant osteoblastic cell line MG63 on monolayer, quiescent bovine aorta EC. MG63-CM and MG63-CM + CoCl2 significantly increased EC survival in serum-starved conditions, without inducing EC proliferation. Furthermore, MG63-CM and MG63-CM + CoCl2, both containing high amounts of vascular endothelial growth factor (VEGF), induced relevant phenotypic changes in EC (all P < 0.01) involving increase of nucleoli/chromatin condensations, nucleus-to-cytosol ratio, capillary-like vacuolated structures, vessel-like acellular areas, migration through Matrigel, growth advantage in reseeding, and factor VIII content. All these actions were significantly inhibited by VEGF and VEGF receptor (VEGFR2) blockade. Of particular importance, a set of similar effects were detected in a human microvascular endothelial cell line (HMEC). With regard to gene expression, incubation with MG63-CM abolished endogenous VEGF mRNA and protein but induced a clear-cut increase in VEGFR2 mRNA expression in EC. In terms of mechanism, MG63-CM activates protein kinase B (PKB)/Akt, p44/p42-mitogen-activated protein kinase (MAPK)-mediated pathways, as suggested by both inhibition and phosphorylation experiments. In conclusion, tumor cells activate confluent, quiescent EC, promoting survival, phenotypic, and gene expression changes. Of importance, VEGF antagonism converts MG63-CM from protective to EC-damaging effects.

vascular endothelial growth factor receptor 2; MG63-conditioned medium


Address for reprint requests and other correspondence: C. Caramelo Díaz, Clínica de la Concepción, Universidad Autónoma de Madrid, Av. Reyes Católicos 2, 28040 Madrid, Spain.




This article has been cited by other articles:


Home page
 Am. J. Physiol. Cell Physiol.Home page
F. Neria, C. Caramelo, H. Peinado, F. R. Gonzalez-Pacheco, J. JP. Deudero, A. J. de Solis, R. Fernandez-Sanchez, S. Penate, A. Cano, and M{a} A. Castilla
Mechanisms of endothelial cell protection by blockade of the JAK2 pathway
Am J Physiol Cell Physiol, March 1, 2007; 292(3): C1123 - C1131.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
M. N. Younes, Y. W. Park, Y. D. Yazici, M. Gu, A. A. Santillan, X. Nong, S. Kim, S. A. Jasser, A. K. El-Naggar, and J. N. Myers
Concomitant inhibition of epidermal growth factor and vascular endothelial growth factor receptor tyrosine kinases reduces growth and metastasis of human salivary adenoid cystic carcinoma in an orthotopic nude mouse model.
Mol. Cancer Ther., November 1, 2006; 5(11): 2696 - 2705.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
F. R. Gonzalez-Pacheco, J. J. P. Deudero, M. C. Castellanos, M. A. Castilla, M. V. Alvarez-Arroyo, S. Yague, and C. Caramelo
Mechanisms of endothelial response to oxidative aggression: protective role of autologous VEGF and induction of VEGFR2 by H2O2
Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1395 - H1401.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.